TrialFrontiers in immunology2025

Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia.

Qingyang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.